United Therapeutics (UTHR) Tops Q1 EPS by 19c, Miss on Revenues

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. ANT
3. SPY
4. FFAI
5. FFR
6. META
7. FICO
8. CART
9. LLY
10. TSLA

Go back to United Therapeutics (UTHR) Tops Q1 EPS by 19c, Miss on Revenues

JMP Securities Downgrades SteadyMed (STDY) to Market Perform Following Acquisition

May 1, 2018 3:25 AM EDT

JMP Securities downgraded SteadyMed (NASDAQ: STDY) from Market Outperform to Market Perform.

Analyst Donald Ellis steps to the sideline following the recent acquisition by United Therapeutics (NASDAQ: UTHR). The analyst is not expecting a competing offer to... More

Pre-Open Movers 04/30: (STDY) (ANDV) (FDC) Higher; (CTB) (S) (ARNC) Lower (more...)

April 30, 2018 9:27 AM EDT

Today's Pre-Open Movers

SteadyMed Ltd. (NASDAQ: STDY) 81.1% HIGHER; United Therapeutics Corporation (NASDAQ: UTHR) and SteadyMed Ltd. (NASDAQ: STDY) announced today the signing of a definitive merger agreement under which United Therapeutics will acquire SteadyMed for $4.46 per share in cash at closing and an additional $2.63 per share in cash upon the achievement of a milestone related to the commercialization of Trevyent®. The transaction, including the $75 million in contingent consideration, is valued at $216 million.

Pluristem Therapeutics Inc. (Nasdaq:... More